Q4 Profit Crashes 99.7% – Star Health’s Expansion Story Faces Reality Check

India’s largest standalone health insurer, Star Health and Allied Insurance Co. Ltd., saw its shares fall by 4% on April 30, after posting a staggering 99.7% drop in net profit for the fourth quarter of FY25. The stock, trading at ₹384.7, is now down over 57% from its IPO price of ₹900, highlighting investor concerns amid rising claims and underwriting losses, despite broader annual growth figures. (Source: www.cnbctv18.com)

A Disappointing Q4 Despite Top-Line Growth

For the quarter ended March 31, 2025, Star Health reported a net profit of ₹0.5 crore, down from ₹142.3 crore in the fourth quarter of FY24. While net earned premiums grew 11.9% year-over-year to ₹3,798.3 crore, rising claim ratios and healthcare inflation significantly eroded profitability.

The biggest blow came from its underwriting loss, which ballooned to ₹275.2 crore from ₹91.8 crore in the year-ago quarter, indicating that growing costs were outpacing the premiums earned. The company’s combined ratio, a key metric indicating claims and expenses as a proportion of premium, rose to 101.1%, compared to 97.2% in FY24, breaching the 100% threshold and signaling operational strain. A combined ratio above 100% typically means the company is paying more in claims and expenses than it earns in premiums, which is unsustainable in the long term. (Source: www.cnbctv18.com)

FY25 Full-Year Highlights: Growth Amid Challenges

Despite the Q4 stumble, Star Health’s full-year FY25 numbers painted a more resilient picture:

• Gross Written Premium (GWP): ₹16,781 crore, up 10% from FY24
• Profit After Tax (PAT): ₹787 crore (under IFRS accounting)
• Solvency Ratio: 2.21x (well above the IRDAI’s minimum of 1.5x)
• Lives Covered: 2.3 crore
• Claims Settled: ₹10,350 crore

The company also emphasized expansion in semi-urban and rural India, which contributed to over 51% of total lives covered and 60% of all claims settled. This outreach was supported by an 11 percent increase in its agent base, taking the network to over 7.75 lakh agents. Star Health has been strategically focusing on underserved geographies to tap into first-time insurance buyers, further cementing its retail market leadership. (Source: www.cnbctv18.com)

CEO Outlook: Expansion and Affordability as Twin Goals

Speaking on the results, Anand Roy, MD & CEO, reiterated the company’s focus on growth, accessibility, and service enhancement despite a challenging macro environment:

“Star Health continues to lead the retail health insurance space with strong growth in new business and a commitment to expanding our reach across India. Despite challenges such as rising healthcare costs, we remain focused on enhancing our claims service and providing affordable coverage to millions of Indians.”

Roy also mentioned investments in claims infrastructure and digital transformation initiatives aimed at improving turnaround times and customer satisfaction, especially in Tier 2 and Tier 3 cities. (Source: www.cnbctv18.com)

Industry Context: Robust Demand, Strong Tailwinds

ROBUST DEMAND
India’s insurance sector has experienced significant growth, with the domestic market expanding at a compound annual growth rate (CAGR) of 17% over the past two decades. It is projected to reach ₹1,930,290 crore (US$ 222 billion) by FY26. Increased awareness, favorable regulatory changes, and greater private sector participation have driven this growth. With rising disposable incomes and a heightened sense of financial preparedness following the COVID-19 pandemic, retail health insurance penetration is steadily increasing.

ATTRACTIVE OPPORTUNITIES

• Robotic Process Automation (RPA) and AI will occupy center stage in insurance, driven by new data channels, improved data processing capabilities, and advancements in AI algorithms.
• Bots will become mainstream in both the front and back offices to automate policy servicing and claims management, providing faster and more personalized customer service.
• The integration of predictive analytics is also helping insurers reduce fraud, assess risk more accurately, and personalise product offerings.

POLICY SUPPORT

• The Indian government has increased the Foreign Direct Investment (FDI) limit in insurance companies from 74% to 100%, enabling full foreign ownership. This is aimed at attracting capital and ensuring domestic reinvestment.
• Insurance coverage was provided for 44.6 crore persons under the PM Suraksha Bima and PM Jeevan Jyoti Yojana during FY23.
• Regulatory reforms, such as sandbox frameworks, digital Know Your Customer (KYC) norms, and product innovation guidelines, have further simplified customer onboarding and policy issuance.

INCREASING INVESTMENTS

• Over the past nine years, the sector attracted nearly ₹54,000 crore (US$ 6.5 billion) in FDI, thanks to relaxed regulations.
• The IPO of LIC of India was the largest in Indian history and the sixth largest globally in FY22, underlining investor interest in the insurance sector.
• Private players are increasingly tapping capital markets to fund their expansion and technology upgradation plans, indicating long-term confidence in the sector’s profitability. (Source: www.ibef.org)

Market Reaction: Profit Woes Overshadow Expansion Success

Investors, however, remained focused on the dismal Q4 numbers and the rising pressure of claims. The 4% drop in share price on April 30 reflects broader skepticism, especially given the stock’s long-term performance, which now trades over 57% below its IPO price.

Concerns around the sustainability of underwriting margins, intensifying competition in the retail segment, and persistent inflation in healthcare services have put downward pressure on investor sentiment. Despite the company’s market leadership, analysts are cautious about near-term earnings visibility. (Source: www.cnbctv18.com)

What’s Next for Star Health?

While Star Health’s long-term fundamentals remain intact, especially its strong solvency and expanding distribution, the rising underwriting losses and healthcare inflation remain risks to watch. The company must strike a balance between growth and profitability, especially in semi-urban and rural segments, where margins are often thinner.

The health insurance sector as a whole is also experiencing increased stress due to medical inflation, post-pandemic health awareness, and a rise in high-value claims. Star Health’s future trajectory will likely depend on its ability to rein in claims costs while sustaining premium growth and maintaining customer satisfaction. Collaborations with hospitals, investment in preventative health programs, and recalibration of premium pricing structures may become critical strategies.

Conclusion

Star Health may have covered 2.3 crore lives and grown its GWP by 10%, but in the world of insurance, claims are king. Rising claims have rattled investors. The company now faces a critical inflection point: either find operational efficiency or risk further erosion of shareholder confidence. Strengthening underwriting practices, embracing digital innovation, and managing costs will be key to restoring investor trust and driving future growth.

Disclaimer Note: The securities quoted, if any, are for illustration only and are not recommendatory. This article is for education purposes only and shall not be considered as a recommendation or investment advice by Equentis – Research & Ranking. We will not be liable for any losses that may occur. Investments in the securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI, membership of BASL & the certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of returns to investors.

FAQs